Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126618161 | 12661816 | 1 | I | 201605 | 20160810 | 20160817 | 20160817 | EXP | US-ABBVIE-16P-163-1698534-00 | ABBVIE | 74.60 | YR | F | Y | 0.00000 | 20160817 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126618161 | 12661816 | 1 | PS | CREON | PANCRELIPASE AMYLASEPANCRELIPASE LIPASEPANCRELIPASE PROTEASE | 1 | Oral | UNKNOWN | 20725 | 24000 | DF | CAPSULE | BID | ||||||
| 126618161 | 12661816 | 2 | C | SUCRALFATE. | SUCRALFATE | 1 | 0 | ||||||||||||
| 126618161 | 12661816 | 3 | C | PROBIOTIC | PROBIOTICS NOS | 1 | 0 | ||||||||||||
| 126618161 | 12661816 | 4 | C | TRAMADOL. | TRAMADOL | 1 | 0 | ||||||||||||
| 126618161 | 12661816 | 5 | C | OXYCODONE | OXYCODONE | 1 | 0 | ||||||||||||
| 126618161 | 12661816 | 6 | C | ELIQUIS | APIXABAN | 1 | 0 | ||||||||||||
| 126618161 | 12661816 | 7 | C | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126618161 | 12661816 | 8 | C | PRAVASTATIN. | PRAVASTATIN | 1 | 0 | ||||||||||||
| 126618161 | 12661816 | 9 | C | CYANOCOBALAMIN. | CYANOCOBALAMIN | 1 | 0 | ||||||||||||
| 126618161 | 12661816 | 10 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 126618161 | 12661816 | 11 | C | SOTALOL. | SOTALOL | 1 | 0 | ||||||||||||
| 126618161 | 12661816 | 12 | C | SODIUM BICARBONATE. | SODIUM BICARBONATE | 1 | 0 | ||||||||||||
| 126618161 | 12661816 | 13 | C | HCTZ | HYDROCHLOROTHIAZIDE | 1 | 0 | ||||||||||||
| 126618161 | 12661816 | 14 | C | ALBUTEROL. | ALBUTEROL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126618161 | 12661816 | 1 | Pancreatic insufficiency |
| 126618161 | 12661816 | 2 | Product used for unknown indication |
| 126618161 | 12661816 | 3 | Product used for unknown indication |
| 126618161 | 12661816 | 4 | Product used for unknown indication |
| 126618161 | 12661816 | 5 | Product used for unknown indication |
| 126618161 | 12661816 | 6 | Product used for unknown indication |
| 126618161 | 12661816 | 7 | Product used for unknown indication |
| 126618161 | 12661816 | 8 | Product used for unknown indication |
| 126618161 | 12661816 | 9 | Product used for unknown indication |
| 126618161 | 12661816 | 10 | Product used for unknown indication |
| 126618161 | 12661816 | 11 | Product used for unknown indication |
| 126618161 | 12661816 | 12 | Product used for unknown indication |
| 126618161 | 12661816 | 13 | Product used for unknown indication |
| 126618161 | 12661816 | 14 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126618161 | 12661816 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126618161 | 12661816 | Blood potassium increased | |
| 126618161 | 12661816 | Dyspnoea | |
| 126618161 | 12661816 | Malnutrition |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |